Surgicure Technologies, Inc.

Surgicure Technologies, Inc. is a medical device company specializing in airway management solutions for civilian and military healthcare applications. The company's flagship product, the HORSESHOE™, is a novel endotracheal (ET) tube securement device designed to address critical safety and comfort challenges in critical care settings. The HORSESHOE™ features a patented off-the-face horseshoe-shaped design with a robust locking mechanism, integrated molar props, and an adjustable track that accommodates ET tubes sized 6.5 to 10 mm. The device is engineered to eliminate medical device-related pressure injuries (MDRPIs) on the face by operating independent of facial skin or lip contact, eliminating the need for adhesives, tape, wires, or additional dressings that commonly cause pressure points and irritation. The HORSESHOE™ facilitates rapid ET tube repositioning via its smooth locking track, enabling assessment and cleaning of facial skin while maintaining airway security. Clinical applications include support for chemotherapy patients with TENS devices, patients with facial trauma, pressure injuries, burns, beards, and emaciated patients. The device supports essential VAP (ventilator-associated pneumonia) prevention practices per 2022 ICHE Guidelines and complies with International NPIAP MDRPI Prevention Guidelines. Surgicure is backed by prominent venture investors including Techstars, BakerBridge Capital, NSF Innovation Corps, and others. The company operates from Cambridge, Massachusetts, and is committed to reducing unplanned extubations, enhancing patient comfort, and standardizing ET tube stabilization practices across critical care environments.